4214 2.5 (Onglyza saxagliptin 2.5 mg)
Generic Name: saxagliptin
Pill imprint 4214 2.5 has been identified as Onglyza saxagliptin 2.5 mg.
Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza saxagliptin 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- saxagliptin
- Imprint:
- 4214 2.5
- Strength:
- saxagliptin 2.5 mg
- Color:
- Yellow
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-4214
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00310-6100 | AstraZeneca Pharmaceuticals LP |
Note: Inactive ingredients may vary.
More about Onglyza (saxagliptin)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
